- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/70 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 239/70
Total number of patents in this class: 507
10-year publication summary
|
24
|
28
|
34
|
28
|
25
|
16
|
32
|
9
|
16
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4119 |
45 |
| Array BioPharma Inc. | 438 |
21 |
| Boehringer Ingelheim International GmbH | 4485 |
20 |
| Merck Sharp & Dohme LLC | 3738 |
14 |
| F. Hoffmann-La Roche AG | 7800 |
12 |
| Duquesne University of the Holy Spirit | 122 |
12 |
| PTC Therapeutics, Inc. | 470 |
10 |
| Reata Pharmaceuticals, Inc. | 111 |
10 |
| Janssen Pharmaceutica N.V. | 3160 |
8 |
| Bristol-myers Squibb Company | 4764 |
7 |
| Merck Sharp & Dohme Corp. | 2184 |
7 |
| Tetra Discovery Partners, LLC | 11 |
7 |
| Universal Display Corporation | 2098 |
7 |
| Samsung SDI Co., Ltd. | 10745 |
6 |
| The Regents of the University of Michigan | 5023 |
6 |
| Hoffmann-La Roche Inc. | 3825 |
5 |
| Idemitsu Kosan Co., Ltd. | 4263 |
5 |
| ArQule, Inc. | 132 |
5 |
| Chimerix, Inc. | 87 |
5 |
| ELC Management LLC | 1165 |
5 |
| Other owners | 290 |